Innovative Therapeutics in Oncology and Neuroscience
19
Zai Lab's Increasing Global Footprint and Growing Scale
Zai Lab Operations Today
·
•
•
Research & Development
>50 clinical trials ongoing / planned
No reliance on CROS
Discovery operations in Shanghai,
Suzhou, California, and Cambridge
Shanghai
(HQ & R&D)
California
Cambridge
(R&D, BD, etc.)
Europe
(R&D, BD, etc.)
(BD)
Guangzhou
(commercial)
Commercial
Commercial presence in mainland
China, Hong Kong, Taiwan
and Macau
Sales force experience in all
top 10 innovative drugs in China
Note: Employee numbers as of December 31, 2023.
Headquarters / Regional Centers Zai Offices
~2.1K
employees
~760 R&D
~1,140 Commercial
Others
Suzhou
Beijing
(clinical & regulatory)
(manufacturing, R&D)
Taiwan
(commercial)
Hong Kong
(commercial)
.
Manufacturing
Two cGMP-compliant
manufacturing facilities
R&D center and Suzhou campus
under development
zajlǝbView entire presentation